Advertisement
Loading...

Liminatus Pharma, Inc. Class A Common Stock

LIMNNASDAQ
Healthcare
Biotechnology
$0.27
$0.08(43.11%)
U.S. Market is Open • 13:15

Why Is Liminatus Pharma, Inc. Class A Common Stock (LIMN) Stock Up Today?

Live update on LIMN's stock movement with key data on price change, volume, technical indicators, sector trends, and analyst sentiment.

Day Change
43.11%
43.11%
Volume (Unusual)
286.54M
7620.00%
Open / Previous Close
$0.31 / $0.19
Day Range (Low / High)
$0.26 - $0.36

Summary

Liminatus Pharma, Inc. Class A Common Stock (LIMN) is trading up +43.11% at $0.27, reflecting a positive shift in investor sentiment today. The stock opened at $0.31 and has moved between $0.26 and $0.36 so far.

Trading volume is 286543840, which is 7620% above its average, and the price action suggests buying interest.

Technically, LIMN is trading above its 50-day moving average of $0.20 and below its 200-day moving average of $1.15, indicating short-term strength but long-term weakness.

Meyka's AI assigns LIMN a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of -589.15% in 1 month (-$1.33), -100.00% in 1 year ($0.00), and -100.00% in 5 years ($0.00).

View the full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement.
Stay informed and make better investment decisions.

LIMN Technical Signals

Trading over 50-day moving average ($0.20)

Trading below 200-day moving average ($1.15)

Analyst Recommendations data is not available for LIMNAnalyst Recommendations details for LIMN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Price Forecast

1 Month

$-1.33

1 Year

N/A

3 Years

N/A

5 Years

N/A

B
Good63.00

Is this change significant?

5-Day:+4.33%

1-Month:-12.69%

3-Month:-17.99%

What's next?

Next earnings date: 7/30/2025

Frequently Asked Questions